ATTENUATION OF DIABETIC NEPHROPATHY IN STREPTOZOTOCIN INDUCED DIABETIC RATS BY METHANOLIC EXTRACT OF BOUGAINVILLEA SPECTABILIS AERIAL PARTS

Authors

  • N.V.L Suvarchala Reddy V Department of Pharmacology, Gokaraju Rangaraju College of Pharmacy, Hyderabad, Telangana, India
  • M. Ganga Raju Department of Pharmacology, Gokaraju Rangaraju College of Pharmacy, Hyderabad, Telangana, India
  • B. Alekhya Department of Pharmacology, Gokaraju Rangaraju College of Pharmacy, Hyderabad, Telangana, India
  • C.V.S Subrahmanyam Department of Pharmacology, Gokaraju Rangaraju College of Pharmacy, Hyderabad, Telangana, India

Abstract

Diabetic nephropathy has become a leading cause of end stage renal failure worldwide. To develop Complementary and Alternative Medicine for the treatment of diabetic nephropathy, the present study investigated the protective effects of methanolic extract of Bougainvillea spectabilis (MEBS) in streptozotocin-induced diabetic nephropathy. In this study, diabetes was induced by a single injection of streptozotocin (STZ, 45 mg/kg, i.p.) in rats. STZ diabetic rats were treated with oral doses of MEBS (200 and 400 mg/kg) for 8 weeks. At the end of the experimental period body, kidney weight, blood glucose levels, serum and urine parameters were investigated. Antioxidant enzymes and lipid peroxide levels were determined in the kidney along with histopathological examination of the same. MEBS significantly increased body weight, lowered blood glucose levels and ameliorated kidney hypertrophy index in the STZ-diabetic rats. The extract also decreased the levels of creatinine, blood urea nitrogen, total cholesterol, triglycerides, advanced glycation end products and albumin in serum and urine, respectively. MEBS significantly increased the antioxidant parameters in the kidney. Histological evaluation revealed that MEBS treated STZ-diabetic rats demonstrated reduced vacuolar degeneration of tubules; periodic acid Schiff base (PAS) positivity staining intensity in glomeruli and basement membrane thickening. Present findings provide experimental evidence that MEBS has potential antioxidant, antihyperglycemic and anti-glycation activities which might be helpful in slowing the progression of diabetic nephropathy.

Keywords:

Diabetic nephropathy, Streptozotocin, Bougainvillea spectabilis

DOI

https://doi.org/10.25004/IJPSDR.2019.110103

References

1. Forbes JM, Coughlan MT, Cooper ME. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes. 2008;57:1446-1454.
2. Horie K, Miyata T, Maeda K, Miyata S, Sugiyama S, Sakai H, van Ypersole de Strihou C, Monnier VM, Witztum JL, Kurokawa K. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy. Journal of Clinical Investigation. 1997;100:2995-3004.
3. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensinconverting-enzyme inhibition on diabetic nephropathy. The collaborative study group. New England Journal of Medicine. 1993;329:1456-1462.
4. Das S, Barman S. Antidiabetic and antihyperlipidemic effects of ethanolic extract of leaves of Punica granatum in alloxan-induced non-insulin-dependent diabetes mellitus albino rats. Indian Journal of Pharmacology. 2012;44:219-224.
5. Adnyana IK, Sukandar EY, Yuniarto A, Finna S. Anti-obesity effect of the pomegranate leaves ethanol extract (Punica granatum L.) in high fat diet induced mice. International Journal of Pharmacy and Pharmaceutical Sciences. 2014;6:626-631.
6. Butterweck V, Nahrstedt A. What is the best strategy for preclinical testing of botanicals? A critical perspective. Planta Medica. 2012;78:747-754.
7. Gong L, Goswami S, Giacomini KM, Altman RB, Klein TE. Metformin pathways: pharmacokinetics and pharmacodynamics. Pharmacogenet Genomics. 2012;22:820–827.
8. Tikoo K, Bhatt DK, Gaikwad AB, Sharma V, and Kabra DG. Differential effects of tannic acid on cisplatin induced nephrotoxicity in rats. FEBS Letters. 2007;581(10): 2027–2035.
9. Yahagi N, Shimano H, Hasty AH, Matsuzaka T, Ide T, Yoshikawa T, Amemiya-Kudo M, Tomita S, Okazaki H, Tamura Y, Iizuka Y, Ohashi K, Osuga J, Harada K, Gotoda T, Nagai R, Ishibashi S, Yamada N. Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lep(ob)/Lep(ob) mice. Journal of Biological Chemistry. 2002; 277(22):19353–19357.
10. Wu KK, Huan Y. Streptozotocin-induced diabetic models in mice and rats. Current Protocol Pharmacology. 2008;40:1-14.
11. Wang GG, Lu XH, Li W, Zhao X, Zhang C. Protective effects of luteolin on diabetic nephropathy in STZ-induced diabetic rats. Evidence Based Complementary and Alternative Medicine. 2011;2011:1-7.
12. Al-Muammar MN, Khan F. Obesity: the preventive role of the pomegranate (Punica granatum). Nutrition. 2012;28:595-604.
13. Patel AN, Bandwane DD, Mhetre NK. Pomegranate (Punica granatum Linn.) leaves attenuate disturbed glucose homeostasis and hyperglycemia mediated hyperlipidemia and oxidative stress in streptozotocin induced diabetic rats. European Journal of Integrative Medicine. 2014;6:307-321.
14. Zafar M, Naqvi SN. Effects of STZ-induced diabetes on the relative weights of kidney, liver and pancreas in albino rats: a comparative study. International Journal of Morphology. 2010;28:135-142.
15. Lenzen S. The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia. 2008;51:216-226.
16. Shewamene Z, Abdelwuhab M, Birhanu Z. Methanolic leaf extract of Otostegia integrifolia Benth reduces blood glucose levels in diabetic, glucose loaded and normal rodents. BMC Complementary and Alternative Medicine. 2015;15:1-7.
17. Cheng D, Liang B, Li Y. Antihyperglycemic effect of Ginkgo biloba extract in streptozotocin-induced diabetes in rats. Biomed Research International. 2013;2013:1-7.
18. Nesbitt KN. An overview of diabetic nephropathy. Journal of Pharmacy Practice. 2004;17: 75-79.
19. Viswanathan V, Snehalatha C, Kumutha R, Jayaraman M, Ramachandran A. Serum albumin levels in different stages of type 2 diabetic nephropathy patients. Indian Journal of Nephrology. 2004;14:89-92.
20. Sohn E, Kim J, Kim C, Lee YM, Jo K, Shin SD, Kim JH, Kim JS. The extract of Litsea japonica reduced the development of diabetic nephropathy via the inhibition of advanced glycation end products accumulation in db/db mice. Evidence Based Complementary and Alternative Medicine. 2013;2013:1-9.
21. Niedowicz DM, Daleke DL. The role of oxidative stress in diabetic complications. Cell Biochemistry and Biophysics. 2005;43:289-330.
22. King GL, Loeken MR. Hyperglycemia-induced oxidative stress in diabetic complications. Histochemistry and Cell Biology. 2004;122:333-338.

Published

20-01-2019
Statistics
Abstract Display: 417
PDF Downloads: 630
Dimension Badge

How to Cite

“ATTENUATION OF DIABETIC NEPHROPATHY IN STREPTOZOTOCIN INDUCED DIABETIC RATS BY METHANOLIC EXTRACT OF BOUGAINVILLEA SPECTABILIS AERIAL PARTS”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 11, no. 1, Jan. 2019, pp. 16-21, https://doi.org/10.25004/IJPSDR.2019.110103.

Issue

Section

Research Article

How to Cite

“ATTENUATION OF DIABETIC NEPHROPATHY IN STREPTOZOTOCIN INDUCED DIABETIC RATS BY METHANOLIC EXTRACT OF BOUGAINVILLEA SPECTABILIS AERIAL PARTS”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 11, no. 1, Jan. 2019, pp. 16-21, https://doi.org/10.25004/IJPSDR.2019.110103.

Similar Articles

1-10 of 74

You may also start an advanced similarity search for this article.